134 related articles for article (PubMed ID: 29931837)
1. Correcting for targeted and control agent signal differences in paired-agent molecular imaging of cancer cell-surface receptors.
Sadeghipour N; Davis SC; Tichauer KM
J Biomed Opt; 2018 Jun; 23(6):1-11. PubMed ID: 29931837
[TBL] [Abstract][Full Text] [Related]
2. Generalized paired-agent kinetic model for in vivo quantification of cancer cell-surface receptors under receptor saturation conditions.
Sadeghipour N; Davis SC; Tichauer KM
Phys Med Biol; 2017 Jan; 62(2):394-414. PubMed ID: 27997381
[TBL] [Abstract][Full Text] [Related]
3. Quantifying cancer cell receptors with paired-agent fluorescent imaging: a novel method to account for tissue optical property effects.
Sadeghipour N; Davis SC; Tichauer KM
Proc SPIE Int Soc Opt Eng; 2018; 10497():. PubMed ID: 30220772
[TBL] [Abstract][Full Text] [Related]
4. Accounting for pharmacokinetic differences in dual-tracer receptor density imaging.
Tichauer KM; Diop M; Elliott JT; Samkoe KS; Hasan T; St Lawrence K; Pogue BW
Phys Med Biol; 2014 May; 59(10):2341-51. PubMed ID: 24743262
[TBL] [Abstract][Full Text] [Related]
5. Combination photoimmunotherapy with monoclonal antibodies recognizing different epitopes of human epidermal growth factor receptor 2: an assessment of phototherapeutic effect based on fluorescence molecular imaging.
Ito K; Mitsunaga M; Nishimura T; Kobayashi H; Tajiri H
Oncotarget; 2016 Mar; 7(12):14143-52. PubMed ID: 26909859
[TBL] [Abstract][Full Text] [Related]
6. ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer.
England CG; Jiang D; Hernandez R; Sun H; Valdovinos HF; Ehlerding EB; Engle JW; Yang Y; Huang P; Cai W
Mol Pharm; 2017 Oct; 14(10):3239-3247. PubMed ID: 28825843
[TBL] [Abstract][Full Text] [Related]
7. Rinsing paired-agent model (RPAM) to quantify cell-surface receptor concentrations in topical staining applications of thick tissues.
Xu X; Wang Y; Xiang J; Liu JTC; Tichauer KM
Phys Med Biol; 2017 Jun; 62(12):5098-5113. PubMed ID: 28548970
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Molecular Imaging with a Single Gd-Based Contrast Agent Reveals Specific Tumor Binding and Retention in Vivo.
Johansen ML; Gao Y; Hutnick MA; Craig SEL; Pokorski JK; Flask CA; Brady-Kalnay SM
Anal Chem; 2017 Jun; 89(11):5932-5939. PubMed ID: 28481080
[TBL] [Abstract][Full Text] [Related]
9. Anti‑tissue factor antibody‑mediated immuno‑SPECT imaging of tissue factor expression in mouse models of pancreatic cancer.
Sugyo A; Aung W; Tsuji AB; Sudo H; Takashima H; Yasunaga M; Matsumura Y; Saga T; Higashi T
Oncol Rep; 2019 Apr; 41(4):2371-2378. PubMed ID: 30816521
[TBL] [Abstract][Full Text] [Related]
10. Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to
Aghevlian S; Lu Y; Winnik MA; Hedley DW; Reilly RM
Mol Pharm; 2018 Mar; 15(3):1150-1159. PubMed ID: 29314858
[TBL] [Abstract][Full Text] [Related]
11. Polyethylene glycol-conjugated HER2-targeted peptides as a nuclear imaging probe for HER2-overexpressed gastric cancer detection in vivo.
Guan SS; Wu CT; Chiu CY; Luo TY; Wu JY; Liao TZ; Liu SH
J Transl Med; 2018 Jun; 16(1):168. PubMed ID: 29921305
[TBL] [Abstract][Full Text] [Related]
12. Thymidine Kinase PET Reporter Gene Imaging of Cancer Cells In Vivo.
McCracken MN
Methods Mol Biol; 2018; 1790():137-151. PubMed ID: 29858789
[TBL] [Abstract][Full Text] [Related]
13. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
[TBL] [Abstract][Full Text] [Related]
14. Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer.
Evazalipour M; D'Huyvetter M; Tehrani BS; Abolhassani M; Omidfar K; Abdoli S; Arezumand R; Morovvati H; Lahoutte T; Muyldermans S; Devoogdt N
Contrast Media Mol Imaging; 2014; 9(3):211-20. PubMed ID: 24700748
[TBL] [Abstract][Full Text] [Related]
15. Molecular imaging of breast cancer.
Oude Munnink TH; Nagengast WB; Brouwers AH; Schröder CP; Hospers GA; Lub-de Hooge MN; van der Wall E; van Diest PJ; de Vries EG
Breast; 2009 Oct; 18 Suppl 3():S66-73. PubMed ID: 19914546
[TBL] [Abstract][Full Text] [Related]
16. Targeted nuclear imaging of breast cancer: status of radiotracer development and clinical applications.
Kong FL; Kim EE; Yang DJ
Cancer Biother Radiopharm; 2012 Mar; 27(2):105-12. PubMed ID: 21877909
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
[TBL] [Abstract][Full Text] [Related]
18. uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.
Christensen A; Juhl K; Persson M; Charabi BW; Mortensen J; Kiss K; Lelkaitis G; Rubek N; von Buchwald C; Kjær A
Oncotarget; 2017 Feb; 8(9):15407-15419. PubMed ID: 28039488
[TBL] [Abstract][Full Text] [Related]
19. Examining the Feasibility of Quantifying Receptor Availability Using Cross-Modality Paired-Agent Imaging.
Meng B; Sadeghipour N; Folaron MR; Strawbridge RR; Samkoe KS; Tichauer KM; Davis SC
Mol Imaging Biol; 2022 Feb; 24(1):23-30. PubMed ID: 34286423
[TBL] [Abstract][Full Text] [Related]
20. Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts.
Liu X; Dong C; Shi J; Ma T; Jin Z; Jia B; Liu Z; Shen L; Wang F
Oncotarget; 2017 Jan; 8(4):6364-6375. PubMed ID: 28031526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
